The rationale for B lymphocyte depletion in Graves’ disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option - El Fassi, D; Nielsen, C H; Hasselbalch, H C; Hegedüs, L (Eur J Endocrinol, 2006)